SCHEMBL30722000

SCHEMBL30722000

CCC[C@H]1O[C@H](CO)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(=O)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR4 O00206 10/20 0.38
▸ PRKCA P17252 2/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ PRKCG P05129 1/20 0.38
▸ PRKCB P05771 1/20 0.38
▸ PRKCH P24723 1/20 0.38
▸ PRKCE Q02156 1/20 0.38
▸ PRKCQ Q04759 1/20 0.38
▸ PRKCD Q05655 1/20 0.38
▸ PRKD1 Q15139 1/20 0.38
▸ LY96 Q9Y6Y9 6/20 0.35
▸ RPS6KA3 P51812 1/20 0.35
▸ CA1 P00915 4/20 0.33
▸ CA2 P00918 4/20 0.33
▸ CA4 P22748 4/20 0.33
▸ CA5A P35218 4/20 0.33
▸ CA5B Q9Y2D0 4/20 0.33
▸ CA12 O43570 3/20 0.33
▸ CA7 P43166 3/20 0.33
▸ LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30721980 0.88 LMNA (0.45) CA1CA2CA4CA5ACA5B
SCHEMBL30722010 0.84 TLR4 (0.35) TLR4PRKCAPRKD3PRKCGPRKCB
SCHEMBL26987623 0.78 PYGB (0.43) CA1CA2LMNA
SCHEMBL26988988 0.78 PYGB (0.43) CA1CA2LMNA
SCHEMBL19079026 0.75 LMNA (0.46) TLR4LY96CA1CA2CA12
SCHEMBL26989644 0.75 MAPK1 (0.41) LMNA
SCHEMBL30980616 0.74 LMNA (0.54) RPS6KA3CA1CA2CA12LMNA
SCHEMBL31553406 0.73 TLR4 (0.30) TLR4
SCHEMBL26988970 0.72 MAPK1 (0.33) TLR4CA1CA2CA12LMNA
SCHEMBL31553396 0.72 LMNA (0.34) CA1CA2CA12LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154188-A1 C-GLYCOSIDES AS ANTI-INFLAMMATORY AGENTS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2025-05-15 — — US disclosed
EP-4551582-A1 C-GLYCOSIDES AS ANTI-INFLAMMATORY AGENTS University of Pittsburgh - of the Commonwealth System of Higher Education (US) 2025-05-14 — — EP disclosed
WO-2024010959-A1 C-GLYCOSIDES AS ANTI-INFLAMMATORY AGENTS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2024-01-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250154188-A1 C-GLYCOSIDES AS ANTI-INFLAMMATORY AGENTS TLR4, TLR1, TLR6 TLR4 1/4885PRKCA 497/4885PRKD3 780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback